The U.S. FDA’s final guidance for clinical trial inspections conducted under the bioresearch monitoring (BiMo) program seems to deviate little if at all from the 2024 draft, but that is precisely the ...
CLEVELAND, Feb. 01, 2024 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (ABEO) today announced, as part of the review process by the U.S. Food and Drug Administration (FDA) for the Biologics License ...
CLEVELAND, March 18, 2024 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (ABEO) today reported financial results for the full year of 2023 and provided an update on progress toward achieving key ...
The Food and Drug Administration is inspecting far fewer pharmaceutical companies conducting clinical research as it adjusts to the post-pandemic world and a smaller workforce, which an auditor warned ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback